The Food and Drug Administration has approved the kinase inhibitor lenvatinib (Lenvima) for the treatment of differentiated thyroid cancer, the agency... More »
Palbociclib, a cyclin-dependent kinase 4/6 inhibitor, has been approved by the Food and Drug Administration for treating postmenopausal women with est... More »
Palbociclib, a cyclin-dependent kinase 4/6 inhibitor, has been approved by the Food and Drug Administration for treating postmenopausal women with est... More »
SILVER SPRING, MD. – The majority of a Food and Drug Administration advisory panel agreed that the risk-benefit profile of panobinostat as add-on treatment to bortezomib and dexamethasone did not...
Close to 8 million women aged 21-65 years were not screened for cervical cancer in the past 5 years even though the disease claims nearly 4,000 lives per year, according to 2012 data, the Centers for...
Close to 8 million women aged 21-65 years were not screened for cervical cancer in the past 5 years even though the disease claims nearly 4,000 lives per year, according to 2012 data, the Centers for...
SILVER SPRING, MD. – The widespread and long-term use of sunscreens demands that manufacturers provide more long-term safety data and information on how the active ingredients affect the health of...
SILVER SPRING, MD. – The widespread and long-term use of sunscreens demands that manufacturers provide more long-term safety data and information on how the active ingredients affect the health of...
A Food and Drug Administration proposal to regulate e-cigarettes does not go far enough, the American Society of Clinical Oncology and the American Association for Cancer Research say.
The two...
More than 60 years after it first became available as a 50-mg tablet, an oral suspension formulation of mercaptopurine has been approved by the Food and Drug Administration.
The oral suspension...